Science Explorer Back to mapMap
Discussion
Company · Carros · France

Arkopharma (France)

arkopharma.comROR OpenAlex
Research works
16
▼ 78% vs 2018-21
Citations
1.3k
76.8 per fractional work
Top-10% rate
0.0%
all institutions 10.0%
Open access
16%
world 40%
International
22%
world 18%
Arkopharma (France)

Not ranked overall: Arkopharma (France) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Arkopharma (France) work in?

In all years, 50% of research at Arkopharma (France) is in Health Sciences, 39% in Life Sciences. Its largest fields are Medicine (44%), Agricultural and Biological Sciences (16%), Biochemistry, Genetics and Molecular Biology (13%). It does 1.7× the world's share of Life Sciences.

Health Sciences: 8 fractional works · 49.8% of its workMedicine: 7 fractional works · 43.7% of its workPathology and Forensic Medicine: 2 fractional works · 14.6% of its workPharmacology: 1 fractional works · 8.1% of its workComplementary and alternative medicine: 1 fractional works · 5.0% of its workBiochemistry: 1 fractional works · 3.8% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 3.8% of its workEpidemiology: 1 fractional works · 3.2% of its workSurgery: 0 fractional works · 2.0% of its workNeurology: 0 fractional works · 1.5% of its workPhysiology: 0 fractional works · 1.0% of its workInfectious Diseases: 0 fractional works · 0.5% of its workNursing: 1 fractional works · 4.6% of its workNutrition and Dietetics: 1 fractional works · 4.6% of its workHealth Professions: 0 fractional works · 1.5% of its workGeneral Health Professions: 0 fractional works · 1.5% of its workLife Sciences: 6 fractional works · 38.8% of its workAgricultural and Biological Sciences: 3 fractional works · 16.1% of its workPlant Science: 2 fractional works · 9.3% of its workFood Science: 1 fractional works · 4.4% of its workEcology, Evolution, Behavior and Systematics: 0 fractional works · 2.4% of its workBiochemistry, Genetics and Molecular Biology: 2 fractional works · 13.1% of its workMolecular Biology: 1 fractional works · 7.4% of its workCancer Research: 0 fractional works · 3.0% of its workBiotechnology: 0 fractional works · 1.3% of its workGenetics: 0 fractional works · 0.9% of its workBiochemistry: 0 fractional works · 0.5% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 3.7% of its workPharmacology: 1 fractional works · 3.7% of its workImmunology and Microbiology: 1 fractional works · 3.2% of its workImmunology: 0 fractional works · 2.7% of its workVirology: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNeuroscience: 0 fractional works · 2.7% of its workCognitive Neuroscience: 0 fractional works · 2.0% of its workBiological Psychiatry: 0 fractional works · 0.7% of its workPhysical Sciences: 1 fractional works · 7.2% of its workChemistry: 1 fractional works · 4.1% of its workOrganic Chemistry: 0 fractional works · 2.7% of its workAnalytical Chemistry: 0 fractional works · 1.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEarth and Planetary Sciences: 0 fractional works · 1.2% of its workGeophysics: 0 fractional works · 0.8% of its workGeochemistry and Petrology: 0 fractional works · 0.4% of its workMaterials Science: 0 fractional works · 1.0% of its workMaterials Chemistry: 0 fractional works · 1.0% of its workEnergy: 0 fractional works · 0.5% of its workRenewable Energy, Sustainability and the Environment: 0 fractional works · 0.5% of its workEnvironmental Science: 0 fractional works · 0.4% of its workPollution: 0 fractional works · 0.4% of its workSocial Sciences: 1 fractional works · 4.2% of its workPsychology: 0 fractional works · 2.7% of its workExperimental and Cognitive Psychology: 0 fractional works · 2.7% of its workSocial Sciences: 0 fractional works · 1.5% of its workUrban Studies: 0 fractional works · 1.5% of its workALL ITS WORKArkopharma(France)16fractional works, all years
Life Sciences39%Physical Sciences7%Health Sciences50%Social Sciences4%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 15 fields, with their numbers
    1. Medicine743.7%
    2. Nursing14.6%
    3. Health Professions01.5%
    1. Agricultural and Biological Sciences316.1%
    2. Biochemistry, Genetics and Molecular Biology213.1%
    3. Pharmacology, Toxicology and Pharmaceutics13.7%
    4. Immunology and Microbiology13.2%
    5. Neuroscience02.7%
    1. Chemistry14.1%
    2. Earth and Planetary Sciences01.2%
    3. Materials Science01.0%
    4. Energy00.5%
    5. Environmental Science00.4%
    1. Psychology02.7%
    2. Social Sciences01.5%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at Arkopharma (France)?

Ranked on the quality score, D. Guédon lead among researchers whose main affiliation is Arkopharma (France).

  1. 1 D. Guédon France · #2,117,995 worldwide 939 citations · 20 works
All ranked researchers at Arkopharma (France)

What are the most cited papers from Arkopharma (France)?

The most cited paper from Arkopharma (France) is "Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans" (Abdul G. Dulloo, Claudette Duret, Dorothée Rohrer et al., 1999), with 928 citations. Next come "Green tea and thermogenesis: interactions between catechin-polyphenols, caffeine and sympathetic activity" (435) and "Recent findings of green tea extract AR25 (Exolise) and its activity for the treatment of obesity" (306).

Most cited papers
#PaperReleasedCitations
1 Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans Abdul G. Dulloo, Claudette Duret, Dorothée Rohrer et al. · American Journal of Clinical Nutrition Open access Dec 1999 928
2 Green tea and thermogenesis: interactions between catechin-polyphenols, caffeine and sympathetic activity Abdul G. Dulloo, Josiane Seydoux, Lucien Girardier et al. · International Journal of Obesity Feb 2000 435
3 Recent findings of green tea extract AR25 (Exolise) and its activity for the treatment of obesity Ph. Chantre, Denis Lairon · Phytomedicine 2002 306
4 Antioxidative activities of Olea europaea leaves and related phenolic compounds Bernard Le Tutour, D. Guédon · Phytochemistry Apr 1992 239
5 Green tea extract (AR25®) inhibits lipolysis of triglycerides in gastric and duodenal medium in vitro Christine Juhel, Martine Armand, Yan Pafumi et al. · The Journal of Nutritional Biochemistry 2000 200
All 39 most cited papers, with filters and sorting

Which research topics does Arkopharma (France) publish most on?

By volume in 2022-now: Sleep and related disorders, Pain Management and Placebo Effect, Acupuncture Treatment Research Studies and Algal biology and biofuel production.

Sleep and related disord…0Sleep and related disorders: 0 fractional worksPain Management and Plac…0Pain Management and Placebo Effect: 0 fractional worksAcupuncture Treatment Re…0Acupuncture Treatment Research Studies: 0 fractional worksAlgal biology and biofuel production: 0 fractional worksEnzyme Catalysis and Immobilization: 0 fractional works
Experimental and Cognitive PsychologyCognitive NeuroscienceComplementary and alternative medicineRenewable Energy, Sustainability and the Environment1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Sleep and related disorders Experimental and Cognitive Psychology 0 works
  2. 2 Pain Management and Placebo Effect Cognitive Neuroscience 0 works
  3. 3 Acupuncture Treatment Research Studies Complementary and alternative medicine 0 works
  4. 4 Algal biology and biofuel production Renewable Energy, Sustainability and the Environment 0 works
  5. 5 Enzyme Catalysis and Immobilization Molecular Biology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available16.0%not open84.0%

World: 40% of research is openly available.

with international co-authors22.0%domestic only78.0%

World: 18% is written across borders.

How has Arkopharma (France)'s research output changed?

Output in 2022-2025 was 78% lower than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Arkopharma (France) as a percentage of every work published that year, 0.000017% in 2019.

0.00010%0.00020%0.00030%Arkopharma (France)0.0000031% in 2024200020102020

Fractional works of Arkopharma (France) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Carros

All research institutions in Carros

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Arkopharma (France). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.